HilleVax, Inc. Quarterly Operating Income (Loss) in USD from Q1 2021 to Q4 2024
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
HilleVax, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2021 to Q4 2024.
- HilleVax, Inc. Operating Income (Loss) for the quarter ending December 31, 2024 was -$36.2M, a 10.3% increase year-over-year.
- HilleVax, Inc. Operating Income (Loss) for the twelve months ending December 31, 2024 was -$155M, a 16.5% decline year-over-year.
- HilleVax, Inc. annual Operating Income (Loss) for 2024 was -$155M, a 16.5% decline from 2023.
- HilleVax, Inc. annual Operating Income (Loss) for 2023 was -$133M, a 105% decline from 2022.
- HilleVax, Inc. annual Operating Income (Loss) for 2022 was -$65.1M, a 21.9% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)